WELCOME
Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific.
All over the world around 17,000 employees are committed to improving the quality of life of critically- and chronically-ill patients with innovative products for patients in hospitals and outpatients.
| NEWS | CONGRESSES |
|---|
Fresenius SE: Q1 2008 - Successful start into 2008 30.04.2008 
Fresenius Kabi strengthens its position in i.v. drugs by acquiring Dabur Pharma, a leading manufacturer of oncology generics 20.04.2008
Fresenius achieves record financial results in 2007
Positive outlook for 2008 20.02.2008
|
Join us at the 30th ESPEN Congress; September 13. - 16., 2008, Florence, Italy
Visit us at the 21st ESICM Annual Congress; September 21. - 24., 2008, Lisbon, Portugal
Come to see us at the 40th World Forum for Medicine: MEDICA 2008; November 19. - 22., 2008, Düsseldorf, Germany
|
